Cargando…
Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis
Sirolimus, an immunosuppressant option for kidney transplant recipients, may reduce cancer risk by interrupting the mammalian target of rapamycin pathway. However, studies of sirolimus and cancer incidence in kidney recipients have not been definitive, and have had limited ability to examine specifi...
Autores principales: | Yanik, Elizabeth L, Siddiqui, Kulsoom, Engels, Eric A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567030/ https://www.ncbi.nlm.nih.gov/pubmed/26108799 http://dx.doi.org/10.1002/cam4.487 |
Ejemplares similares
-
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
por: Andronesi, Andreea G., et al.
Publicado: (2019) -
Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone
por: Jackson‐Spence, Francesca, et al.
Publicado: (2018) -
Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study
por: Dai, Xiao‐Yu, et al.
Publicado: (2020) -
“Not just another meta‐analysis”: Sources of heterogeneity in psychosocial treatment effect on cancer survival
por: Mirosevic, Spela, et al.
Publicado: (2019) -
Incidence and survival of rare cancers in the US and Europe
por: Botta, Laura, et al.
Publicado: (2020)